GSK’s Steady Financial Outlook Despite Zantac Lawsuit Costs Business 8 November 2024 GSK has experienced a notable profit decline following significant charges from the Zantac litigation settlements. Despite this, the company maintains…
GSK Finalises £1.68 Billion Settlement for Zantac Cancer Claims Business 10 October 2024 GSK has taken a significant step forward by agreeing to a £1.68 billion settlement to address Zantac cancer claims.This settlement…
GSK to Settle Zantac Lawsuits with $2.2 Billion Agreement Business 9 October 2024 GSK has reached a settlement to resolve nearly 80,000 lawsuits linked to the heartburn medication Zantac.This decision entails a financial…
Delaware Supreme Court Hears Zantac Cancer Case Appeal by GSK and Pfizer Business 28 August 2024 Delaware’s highest judicial authority is poised to address a significant appeal. At its core are allegations against major pharmaceutical companies…
Major corporations return to CBI as lobby group rebuilds after misconduct scandal Business 26 August 2024 Several prominent corporations have decided to rejoin the Confederation of British Industry (CBI) following a significant misconduct scandal. The CBI…
GSK Wins Latest Zantac Trial Court Dismisses Cancer Claims Business 6 August 2024 GlaxoSmithKline (GSK) achieved a notable legal win as a jury cleared its drug Zantac of causing cancer. This marks a…
